Cargando…
Salidroside Promotes the Pathological α-Synuclein Clearance Through Ubiquitin-Proteasome System in SH-SY5Y Cells
Parkinson’s disease (PD) is characterized by the loss of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNc) and the presence of Lewy bodies (LBs) in the surviving SNc neurons. LBs formation is caused by the accumulation of α-synuclein (α-syn) or phosphorylated α-syn at serine-129...
Autores principales: | Li, Tao, Feng, Yang, Yang, Ruixin, Wu, Leitao, Li, Ruru, Huang, Lu, Yang, Qian, Chen, Jianzong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917065/ https://www.ncbi.nlm.nih.gov/pubmed/29725300 http://dx.doi.org/10.3389/fphar.2018.00377 |
Ejemplares similares
-
Salidroside Protects Dopaminergic Neurons by Enhancing PINK1/Parkin-Mediated Mitophagy
por: Li, Ruru, et al.
Publicado: (2019) -
Salidroside Protects against MPP+-Induced Neuronal Injury through DJ-1-Nrf2 Antioxidant Pathway
por: Wu, Leitao, et al.
Publicado: (2017) -
Salidroside protects SH-SY5Y from pathogenic α-synuclein by promoting cell autophagy via mediation of mTOR/p70S6K signaling
por: Chen, Shasha, et al.
Publicado: (2019) -
Salidroside Protects Dopaminergic Neurons by Preserving Complex I Activity via DJ-1/Nrf2-Mediated Antioxidant Pathway
por: Li, Ruru, et al.
Publicado: (2019) -
A Matrigel-based 3D construct of SH-SY5Y cells models the α-synuclein pathologies of Parkinson's disease
por: Li, Zhao-Feng, et al.
Publicado: (2022)